Manel Cascallo

Manel Cascallo, PhD

General Director,
EU Subsidiary

More than 12 years experience as CEO of biotech companies
Expert in clinical development of oncolytic adenovirus and author of many peer-reviewed scientific publications

Inventor on several patents for the use of adenovirus as antitumoral agents
Serves as an independent expert for the European Medicines Agencies (EMA)